-
85th ENMC International Workshop on Congenital Muscular Dystrophy. 6th International CMD Workshop. 1st Workshop of the Myo-Cluster Project 'GENRE'. 27-28th October 2000, Naarden, The Netherlands.
Neuromuscul Disord. 2002 Jan;12(1):69-78
PMID: 11731288
-
Remarkable roles of proteolysis on and beyond the cell surface.
Curr Opin Cell Biol. 2000 Oct;12(5):606-12
PMID: 10978897
-
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
Nat Med. 2002 Jan;8(1):35-40
PMID: 11786904
-
Muscular dystrophy--reason for optimism?
Cell. 2002 Jan 11;108(1):5-8
PMID: 11792315
-
Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice.
J Cell Biol. 2002 Apr 1;157(1):137-48
PMID: 11927606
-
Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5616-21
PMID: 11960016
-
ADAM 12 protease induces adipogenesis in transgenic mice.
Am J Pathol. 2002 May;160(5):1895-903
PMID: 12000741
-
A metalloprotease-disintegrin participating in myoblast fusion.
Nature. 1995 Oct 19;377(6550):652-6
PMID: 7566181
-
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.
Nat Med. 1996 Apr;2(4):418-23
PMID: 8597951
-
Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.
J Biochem. 1995 Nov;118(5):959-64
PMID: 8749313
-
Growth hormone and the insulin-like growth factor system in myogenesis.
Endocr Rev. 1996 Oct;17(5):481-517
PMID: 8897022
-
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
Nature. 1996 Nov 28;384(6607):349-53
PMID: 8934518
-
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
J Cell Biol. 1997 Oct 20;139(2):375-85
PMID: 9334342
-
A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo.
J Biol Chem. 1998 Jan 2;273(1):157-66
PMID: 9417060
-
Heparin-binding EGF-like growth factor.
Biochim Biophys Acta. 1997 Dec 9;1333(3):F179-99
PMID: 9426203
-
Spatially- and temporally-restricted expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse embryo.
Mech Dev. 1998 May;73(2):211-5
PMID: 9622634
-
Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
J Clin Invest. 1998 Aug 15;102(4):844-52
PMID: 9710454
-
ADAMs: focus on the protease domain.
Curr Opin Cell Biol. 1998 Oct;10(5):654-9
PMID: 9818177
-
A cellular striptease act.
Science. 1998 Nov 13;282(5392):1279-80
PMID: 9867633
-
Seeking muscle stem cells.
Curr Top Dev Biol. 1999;43:191-219
PMID: 9891887
-
Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion.
Am J Pathol. 1999 May;154(5):1489-501
PMID: 10329602
-
Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.
J Clin Invest. 1999 Aug;104(4):375-81
PMID: 10449429
-
Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain.
Exp Cell Res. 1999 Nov 1;252(2):423-31
PMID: 10527632
-
Muscle regeneration: molecular aspects and therapeutic implications.
Curr Opin Neurol. 1999 Oct;12(5):535-43
PMID: 10590890
-
The ADAM gene family: surface proteins with adhesion and protease activity.
Trends Genet. 2000 Feb;16(2):83-7
PMID: 10652535
-
Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
Gene Ther. 2000 Feb;7(3):201-4
PMID: 10694796
-
Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha -actinin-2, is required for myoblast fusion.
J Biol Chem. 2000 May 5;275(18):13933-9
PMID: 10788519
-
Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy.
Cell Transplant. 2000 Jul-Aug;9(4):551-64
PMID: 11038071
-
RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction.
J Biol Chem. 2000 Nov 10;275(45):34922-30
PMID: 10944520
-
ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3.
Biochem Biophys Res Commun. 2000 Nov 30;278(3):511-5
PMID: 11095942
-
Analysis for transcript expression of meltrin alpha in normal, regenerating, and denervated rat muscle.
J Muscle Res Cell Motil. 2000;21(5):475-80
PMID: 11129438
-
Molecular basis of muscular dystrophies.
Muscle Nerve. 2000 Oct;23(10):1456-71
PMID: 11003781
-
Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
J Cell Biol. 2001 Mar 19;152(6):1207-18
PMID: 11257121
-
An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
Nature. 2001 Sep 20;413(6853):302-7
PMID: 11565031
-
A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.
J Cell Biol. 2001 Oct 1;155(1):123-31
PMID: 11581289
-
Dystrophin and muscular dystrophy: past, present, and future.
Mol Genet Metab. 2001 Sep-Oct;74(1-2):75-88
PMID: 11592805
-
The potential of muscle stem cells.
Dev Cell. 2001 Sep;1(3):333-42
PMID: 11702945
-
The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading.
J Cell Biol. 2000 May 29;149(5):1143-56
PMID: 10831617
-
ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3.
J Biol Chem. 2000 Jun 16;275(24):18574-80
PMID: 10849447
-
Therapeutic possibilities in muscular dystrophy: the hope versus the hype.
Neuromuscul Disord. 2002 Feb;12(2):113-6
PMID: 11738351